Search

Your search keyword '"Halm, Josiah"' showing total 25 results
Start Over Author "Halm, Josiah"
25 results on '"Halm, Josiah"'

4. Gastrointestinal Emergencies in the Oncology Patient

Author

Campagna, Maria-Claudia, George, Marina, Halm, Josiah, Malik, Asifa, Buzdar, Aman U., Series editor, Freedman, Ralph S., Series editor, Manzullo, Ellen F., editor, Gonzalez, Carmen Esther, editor, Escalante, Carmen P., editor, and Yeung, Sai-Ching J., editor

Published
2016
Full Text
View/download PDF

8. Comparison of Health Care Providers Attitudes and Beliefs Regarding Medical Marijuana and Cannabidiol in the Management of Pain and Other Symptoms in Cancer Patients.

Author

Tanco, Kimberson, Lopez, Gabriel, Koyyalagunta, Lakshmi, Fellman, Bryan, Halm, Josiah, Ignatius, Jerry, and Bruera, Eduardo

Subjects
CANNABIDIOL, CANCER pain, COMBINATION drug therapy, ATTITUDES of medical personnel, CANCER patients, COMPARATIVE studies, SURVEYS, HEALTH attitudes, MEDICAL marijuana, DRUG prescribing, DESCRIPTIVE statistics, PHYSICIAN practice patterns, OPIOID analgesics, PAIN management, THERAPEUTICS
Abstract

Background: Medical marijuana (MM) and cannabidiol (CBD) have received increasing attention to manage pain and other symptoms even with limited scientific evidence. Objectives: We examined the attitudes and beliefs of health care providers toward MM and CBD compared to standard treatments for cancer-associated pain and various symptoms. Design: Two sets of anonymous surveys (MM and CBD) containing similar items were completed by clinicians of four symptom-focused specialties. Results: A minority of respondents preferred recommending MM (9%) and CBD (13%), respectively, over opioids for cancer pain, while 11% and 22% felt that MM and CBD, respectively, would be useful to combine with opioids to treat cancer pain. Respondents did not favor MM or CBD over common treatment options for nonpain symptoms. Conclusion: MM and CBD were not preferred over current standard treatments for pain and other symptoms. Responses from the four specialties aligned with unique aspects of their clinical practice. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

12. Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis

Author

Elting, Linda S., Chang, Yu-Chia, Parelkar, Pratibha, Boers-Doets, Christine B., Michelet, Marisol, Hita, Guido, Rouleau, Tanya, Cooksley, Catherine, Halm, Josiah, Vithala, Madhuri, Bossi, Paolo, Escalante, Carmen, Brennan, Michael T., and On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)

Published
2013
Full Text
View/download PDF

14. Comparison of LACE and HOSPITAL Readmission Risk Scores for CMS Target and Nontarget Conditions.

Author

Jones, Stephen L., Cheon, Ohbet, Manzano, Joanna-Grace Mayo, Park, Anne K., Lin, Heather Y., Halm, Josiah K., Juha Baek, Graviss, Edward A., Nguyen, Duc T., Kash, Bita A., and Phillips, Robert A.

Abstract

This study evaluated the utility and performance of the LACE index and HOSPITAL score with consideration of the type of diagnoses and assessed the accuracy of these models for predicting readmission risks in patient cohorts from 2 large academic medical centers. Admissions to 2 hospitals from 2011 to 2015, derived from the Vizient Clinical Data Base and regional health information exchange, were included in this study (291 886 encounters). Models were assessed using Bayesian information criterion and area under the receiver operating characteristic curve. They were compared in CMS diagnosis-based cohorts and in 2 non-CMS cancer diagnosis-based cohorts. Overall, both models for readmission risk performed well, with LACE performing slightly better (area under the receiver operating characteristic curve 0.73 versus 0.69; P = 0.001). HOSPITAL consistently outperformed LACE among 4 CMS target diagnoses, lung cancer, and colon cancer. Both LACE and HOSPITAL predict readmission risks well in the overall population, but performance varies by salient, diagnosis-based risk factors. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results